Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Recruiting · NCT05269316 · Registry updated 2025-04-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors | neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-04-01 | NCT05269316 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Impact Therapeutics, Inc. | 4 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 208 |
| Blacktown Hospital | Blacktown | Australia | 18 |
| Greenville Hospital System University Medical Center (ITOR) | Greenville | United States | 2 |
| Hackensack University Medical Center PARTNER | Hackensack | United States | 2 |
| Linear Clinical Research Limited | Nedlands | Australia | 2 |
| Mary Crowley Cancer Research Centers | Dallas | United States | 1 |
| Mount Sinai | New York | United States | 58 |
| National Taiwan University Hospital | Taipei | Taiwan | 159 |